新体DB:癌症中新体生物标志物的综合数据库
Kimonas Provatas1,2, Candace S Y Chan1,2, Ioannis Kerasiotis1,2
1Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, 1400 Barbara Jordan Boulevard, Austin, TX 78723, United States.
一个新的数据库,neomerDB,列出了癌症特异性生物标志物,称为neomers. 这些从缺失的基因组序列中衍生出的新分子,显示出早期癌症检测和通过液体活检监测的前景.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 生物信息学是一种生物信息学.
背景情况:
- 生物标志物对于癌症查,早期检测和监测至关重要.
- 零基因组是缺失的基因组序列,而新基因组是由癌症突变产生的子集.
研究的目的:
- 开发neomerDB,一个全面的数据库,跨越各种癌症类型和器官的新陈代谢.
- 识别和编目与特定癌症和器官相关的新体.
- 为利用新分子作为癌症生物标志物提供资源.
主要方法:
- 分析了10,000个完整的外基因组和2,658个完整的基因组瘤匹配样本,以确定癌症特异性新陈代谢.
- 询问了76,215个完整的基因组和7,300,947个完整的外基因组,以过生殖系衍生的零和新基因组.
- 开发了具有高级搜索,可视化和下载功能的neomerDB.
主要成果:
- 确定了特定于不同癌症类型和器官的新体的目录.
- 过了由生殖系变异产生的特定种群的nullomers和neomers.
- 从液体活检 (cfDNA,cfRNA) 中检测质母细胞瘤的新体实用性已被证明具有很高的准确性 (AUC 0.98,精确召回 0.99).
结论:
- NeomerDB为癌症生物标志物发现和研究提供了宝贵的资源.
- 新分子代表了一类新的生物标志物,有可能用于非侵入性癌症检测.
- 新体DB平台促进了新体生物标志物的探索和应用,以改善患者的治疗结果.
更多相关视频
11:18Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
